A retrospective study on the prescription pattern of lithium carbonate during 2005-2006 in Turkey


Karadag H., Turkcapar H., Karaoglan A., Orsel S., Guney Z.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, vol.19, 2009 (Peer-Reviewed Journal) identifier

  • Publication Type: Article / Article
  • Volume: 19
  • Publication Date: 2009
  • Journal Name: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
  • Journal Indexes: Science Citation Index Expanded, TR DİZİN (ULAKBİM)

Abstract

Introduction: Lithium is a mood stabilizing agent that may be used in clinical cases like treatment resistant schizophrenia behind its use in mood disorders. Previous studies have shown that substantial variation occurs in the pharmacological treatment of bipolar disorder. Studies showed that nearly half of patients use lithium alone or in combination with other drugs (1, 2). But there are data suggesting that prescription patterns of mood stabilizers have changed over the last few years, with an increase in the prescription of anticonvulsants and a decrease in the use of lithium.